Bed Bath & Beyond's CEO Resigns After Activist Investor Pressure

Following several years of terrible earnings results, Bed Bath & Beyond (NASDAQ: BBBY) came under pressure from three small activist investment funds earlier this year. The funds -- Legion Partners Asset Management, Macellum Advisors, and Ancora Advisors -- have been agitating to replace the company's board and management.

While Bed Bath & Beyond has tried to push back against the activists' demands, the trio is quickly getting much of what they want. Most notably, long-serving CEO Steven Temares resigned abruptly on Monday, paving the way for a new management team to take charge.

Bed Bath & Beyond has stumbled badly

Over the past three fiscal years, Bed Bath & Beyond's results have gone from bad to worse. In fiscal 2016, comparable store sales decreased 0.6%, and adjusted earnings per share fell to $4.58 from $5.04 a year earlier. Comparable sales fell 1.3% in fiscal 2017, while adjusted EPS plunged to $3.12. Finally, comps slid another 1.1% in the recently completed 2018 fiscal year, sending adjusted earnings down to just $2.05 per share.

During this three-year period, Bed Bath & Beyond's EPS actually benefited from share buybacks and a reduction in the federal corporate tax rate. Adjusted pre-tax profit -- a metric that isn't sensitive to those factors -- plummeted more than 70%, from $1.3 billion in fiscal 2015 to just $353 million last year.

In conjunction with its fourth-quarter earnings report last month, Bed Bath & Beyond projected that it would return to earnings growth this year. Management also claimed that a variety of turnaround initiatives designed to reduce inventory, boost gross margin, and cut expenses are starting to bear fruit.

Two people's hands holding a Bed Bath & Beyond gift card
Two people's hands holding a Bed Bath & Beyond gift card

Image source: Bed Bath & Beyond.

However, comp sales and earnings both declined significantly last quarter, so whatever green shoots may exist aren't visible to investors yet. Furthermore, management has repeatedly underestimated the challenges facing the company in recent years, so investors can't be too confident in their relatively optimistic outlook for fiscal 2019.

Activists are getting their way

The activist funds dogging Bed Bath & Beyond have made it clear that they won't be satisfied with anything less than radical change. Following the fourth quarter earnings report, the group criticized the company's strategy and outlook, describing the CEO and board as "removed from reality."

Bed Bath & Beyond attempted to appease the activist funds later in April by refreshing its board. Co-founders Warren Eisenberg and Leonard Feinstein stepped down from their roles as co-chairmen and left the board, along with five of Bed Bath & Beyond's nine independent directors. Five new independent directors were appointed to join then-CEO Steven Temares and the four continuing independent directors. Eight of the current directors have been appointed within the past two years.